Vendor, Raleigh, NC, part of Mayne Pharma Group Limited
Mayne Pharma Commercial LLC
UEI EJMTUZC46YN3, CAGE 4HH72
3 awards and $0 obligated between January 10, 2024 and September 3, 2026, 100% under full and open competition, against 666.3 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79724A0017May 28, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for Halobetasol and TazarotenNAICS 325412, PSC 6505 | $0 |
| 36F79725D0167July 7, 2025, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract AwardNAICS 325412, PSC 6505 | $0 |
| V797D50564January 10, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Short Term Contract ExtensionNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 67 across 3 awards